Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:06:23.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with site header/navigation, indicating access is blocked rather than showing the study record. This reflects an access-control issue rather than a substantive update to the content.
    Difference
    19%
    Check dated 2026-09-21T22:57:37.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, representing a minor update to the page version. No changes to the displayed study content or details are indicated.
    Difference
    0.0%
    Check dated 2026-08-31T17:40:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new line '2018 ( U.S. NIH Grant/Contract )' was added to the study's funding information, indicating NIH support for the trial.
    Difference
    0.0%
    Check dated 2026-08-24T16:36:37.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision label updated from Revision: v3.6.4 to Revision: v3.6.5, signaling a new page version. This update appears to be a backend/versioning change rather than a visible content change.
    Difference
    0.0%
    Check dated 2026-08-10T11:54:41.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a newer release of the page or system.
    Difference
    0.0%
    Check dated 2026-07-27T05:56:39.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.